GGrantIndex
Sort

53,477 grants matching addiction

Cerebellar biobehavioral markers in cannabis users

$543,194
William P Hetrick · Trustees Of Indiana University · R01 · FY2022 · DA

Extracellular vesicles in semen and genital HIV infection and immunity during heroin addiction and methadone or buprenorphine substitution therapy

$543,156
Florian Hladik · University Of Washington · R01 · FY2015 · DA

Imaging Cortical Dopamine Transmission in Alcohol Dependence

$543,149
Rajesh Narendran · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · AA

Smoking Cessation for Head and Neck Cancer Patients

$543,137
Robert A Schnoll · University Of Pennsylvania · R01 · FY2006 · CA

To Test A Payer/Treatment Agency Intervention to Increase Use of Buprenorphine

$543,077
Todd David Molfenter · University Of Wisconsin-Madison · R01 · FY2015 · DA

Genetic and hormonal contributions to sex differences in vulnerability to drug use

$543,059
Wendy Jean Lynch · University Of Virginia · R01 · FY2023 · DA

Intranet-based Tobacco Prevention Program for Children

$543,018
Oregon Research Institute · R01 · FY2005 · CA

Large-scale analysis of functional synapses during circuit plasticity with novel optogenetic sensors

$543,005
Karen Zito · University Of California At Davis · U01 · FY2018 · NS

Identifying specific genetic pathway interactions for drug use and abuse through integrative omics

$543,000
Qian Peng · Scripps Research Institute, The · DP1 · FY2023 · DA

Bupropion for ADHD in Adolescents with Substance Use Disorders

$542,986
Paula Riggs · University Of Colorado Denver · R01 · FY2011 · DA

Preclinical Evaluation of Medications to Treat Polydrug Addiction

$542,924
Nancy K. Mello · Mclean Hospital · R01 · FY2009 · DA

Pharmacotherapies: Efficacy, Mechanisms, and Algorithms

$542,917
University Of Wisconsin Madison · P50 · FY2004 · DA

Compounded Neuronal Damage in Comorbid Cigarette Smoking and Addiction

$542,898
Karmen K Yoder · Indiana University Indianapolis · R01 · FY2019 · AA

Impacts of universal access to HIV/AIDS care among HIV+ injection drug users

$542,769
M-J Milloy · University Of British Columbia · R01 · FY2016 · DA

Bioartificial Brain Slices for Drug Screening

$542,765
Eric Stephen Guire · Innovative Surface Technologies, Inc. · R44 · FY2018 · MH

Ca2+-Dependent Block by Mematine and Selective Inhibition of Overactive NMDA Receptors

$542,736
Jon W. Johnson · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AG

Translational Studies on Early-life Stress and Vulnerability to Alcohol Addiction

$542,689
Jeffrey L. Weiner · Wake Forest University Health Sciences · P01 · FY2014 · AA

Methodology for MH/Drug Prevention & Early Intervention

$542,687
C. Hendricks Brown · University Of South Florida · R01 · FY2008 · MH

COSTS AND BENEFITS OF ALCOHOL SERVICES &INTERVENTIONS

$542,673
University Of Miami Coral Gables · R01 · FY2004 · AA

Drug Abuse: Discovering Ligands for Pertinent GPCRs

$542,667
Marc G. Caron · Duke University · P30 · FY2010 · DA

Glutamate receptor plasticity underlying incubation of methamphetamine craving

$542,558
Marina Elizabeth Wolf · Oregon Health & Science University · R01 · FY2025 · DA

Glutamate receptor plasticity underlying incubation of methamphetamine craving

$542,558
Marina Elizabeth Wolf · Oregon Health & Science University · R01 · FY2023 · DA

Glutamate receptor plasticity underlying incubation of methamphetamine craving

$542,558
Marina Elizabeth Wolf · Oregon Health & Science University · R01 · FY2024 · DA

MRI probes for functional imaging of plasticity signals in the brain

$542,555
Alan Jasanoff · Massachusetts Institute Of Technology · R01 · FY2011 · DA

OPIATE DEPENDENCE: COMBINED NALTREXONE/BEHAVIOR THERAPY

$542,542
New York State Psychiatric Institute · R01 · FY2003 · DA